Earnings call transcript: Sono-Tek misses Q2 2027 estimates as shares fall 11%
Sono-Tek Corp. reported Q2 2027 earnings below expectations, with EPS of $0.02 (vs. $0.04 estimate) and revenue of $5.23M (vs. $5.56M estimate). Shares fell 11.1% premarket. Despite revenue growth and margin expansion, management expects flat to modest growth for the rest of fiscal 2027. The company's backlog grew to $10.79M, driven by large medical and alternative-energy orders.
How this was made
The 30-second read
Why it matters
The earnings miss triggered an 11% pre‑market decline, highlighting investor sensitivity to guidance in small‑cap industrial stocks.
Market read
The report is a primary earnings disclosure for a micro‑cap, offering a timely trading signal.
What to watch
Cash position is robust and capacity expansion plans may unlock higher revenue in FY2028, which the market may undervalue.
Background
Sono-Tek Corp. (SNTE) provides ultrasonic coating systems for medical and alternative‑energy applications.
Market effects
Small‑cap industrial and medical‑device coating segment may see heightened scrutiny on growth forecasts.
US small‑cap equities could experience modest pullback on earnings disappointment.
Limited to niche ultrasonic coating market; no broad macro effect.
Counterpoint
Despite the miss, the strong backlog and margin expansion could support a rebound if guidance improves.
Key entities
- companySono‑Tek Corp.
Manufacturer of ultrasonic coating systems.
